Cancer centers racing to map patients’ genes
April 30, 2013
Major academic medical centers in New York and around the country are spending and recruiting heavily in what has become an arms race within the war on . The investments are based on the belief that the medical establishment is moving toward the routine sequencing of every patient’s genome in the quest for “precision medicine,†a course for prevention and treatment based on the special, even unique characteristics of the patient’s genes. (New York Times)